胡金龙;王静成;颜连启;

• 1:江苏省苏北人民医院骨科

摘要(Abstract)：

<正>全世界每年骨折和骨缺损的患者数以千万计,传统的骨缺损治疗方法有自体骨移植、同种异体骨移植和人工骨移植等。这些方法虽然在实验和临床治疗起到了一定的成果,但均因各种因素使其在临床应用受到一定限制[1～3]:自体骨移植安全性高,有良好的骨诱导性,因而被认为是骨缺损修复的金标准[4-5],但供体来源往往有限,而且手术时间长,并发症多;同种异体骨移植植入后容易吸收,而且容易感染,排斥反应

关键词(KeyWords)： 组织工程;细胞因子;骨缺损

Abstract:

Keywords:

基金项目(Foundation): 江苏省自然科学基金面上项目(编号:BK2011433)

作者(Author): 胡金龙;王静成;颜连启;

Email:

DOI:

参考文献(References)：

• [1]Rozen N,Bick T,Bajayo A,et al.Transplanted blood-derived endotheli-al progenitor cells(EPC)enhance bridging of sheep tibia critical sizedefects[J].Bone,2009,5:918-924.
• [2]Yan F,Yang WL,Yang W.Repairing femur defect using biomaterialsand its features evaluation[J].J Clin Rehabil Tissue Eng Res,2010,16:2963-2966.
• [3]Mohd Janurudin J,Ozeki K,Aoki H.Preparation of a hydroxyapatiteand hydrogen peroxide composite for tooth whitening[J].Biomed MaterEng,2007,2:69-75.
• [4]Brandoff JF,Silber JS,Vaccaro AR.Contemporary alternatives to syn-thetic bone grafts for spine surgery[J].J Orthop Am,2008,37:410-414.
• [5]Maier S,Pelin I,Bulacovschi V.Study on an injectable biomimetichydroxyapatite-atelocollagen composite[J].Rev Med Chi Soc Med NatIasi,2007,4:1079-1083.
• [6]Drosse I,Volkmer E,Capanna R,et al.Tissue engineering for bone de-fect healing:an update on a multi-component approach[J].Injury,2008,2:9-20.
• [7]李章华.骨组织工程支架材料在临床中的应用[J].中国组织工程研究与临床康复,2009,47:9372.
• [8]阳懿,赵承初,孙勇,等.两种骨修复材料兔颅骨骨缺损:X线评估效果[J].中国组织工程研究与临床康复,2010,34:6283-6286.
• [9]夏军,杨丰建,陈杰,等.可注射型骨移植替代物的研究进展[J].中国矫形外科杂志,2006,4:297-299.
• [10]Schmitz JP,Hollinger JO.The critical size defect as an experimentalmodel for craniomandibulofacial nonunions[J].Clin Orthop,1986,205:299-308.
• [11]王文良,张华亮,关静,等.壳聚糖/羟基磷灰石支架修复骨软骨缺损的实验研究[J].中国矫形外科杂志,2008,20:1579-1583.
• [12]Hivard V,Descamps M.In vitro culture of large bone substitutes in a-new bioreactor:importance of the flow direction[J].Biomed Mat,2007,2:174-180.
• [13]Notodihardjo FZ,Kakudo N.Bone regeneration with BMP-2 andhydroxyapatite in critical-size calvarial defects in rats[J].J Cranio-Maxillo-Facial Surg,2012,40:287-291.
• [14]Wada Y,Kataoka H,Yokose S,et al.Changes in osteoblast phenotypeduring differentiation of enzymatically isolated rat calvaria cells[J].Bone,1998,5:479-485.
• [15]Baylink DJ,Finkelman RD,Mohan S.Growth factors to stimulate boneformation[J].J Bone Miner,1993,2:565-572.
• [16]郑旺,高丽娜,李西成.胶原蛋白膜包裹藻酸钙凝胶/骨髓基质细胞/BMP-2复合体修复兔桡骨缺损[J].中国矫形外科杂志,2012,4:363-366.
• [17]Lin YF,Tang W,Wu L,et al.Bone regeneration by BMP-2 enhancedadipose stem cells loading on alginate gel[J].Histochem Cell Biol,2008,129:203-210.
• [18]Liu ZJ,Zhuge Y,Velazquez OC.Trafficking and differentiation of mes-enchymal stem cells[J].J Cell Biochem,2009,6:984-991.
• [19]El Tamer MK,Reis RL.Progenitor and stem cells for bone and cartilageregeneration[J].J Tissue Eng Regen Med,2009,5:327-337.
• [20]Choi JY,Lee HH,Kim HW.Bioactive sol-gel glass added ionomer ce-ment for the regeneration of tooth structure[J].J Mater Sci Mater Med,2008,10:3287-3294.
• [21]贾祎佳,刘强,卢向东.转碱性成纤维细胞生长因子基因组织工程骨修复兔骨缺损[J].中国组织工程研究与临床康复,2011,8:1365-1368.
• [22]Schmidt A,Ladage D,Schink T,et al.Basic fibroblast growth factorcontrols migration in human mesenchymal stem cells[J].Stem Cells,2006,7:1750-1758.
• [23]Chen M,Song K,Rao N,et al.Roles of exogenously regulated bFGF ex-pression in angiogenesis and bone regeneration in rat calvarial defects[J].Int J Mol Med,2011,4:545-553.
• [24]Mayr-Wohlfart U,Waltenberger J,Hausser H,et al.Vascular endotheli-al growth factor stimulates chemotactic migration of primary human oste-oblasts[J].Bone,2002,3:472-477.
• [25]顾晓东,梁庆威.纳米羟基磷灰石/胶原蛋白复合骨结合VEGF修复骨缺损的实验研究[J].中国医科大学学报,2011,10:902-905.
• [26]Yao W,Zhong J,Yu J,et al.IGF-I improved bone mineral density andbody com position of weaver mutant mice[J].Growth Horm IGF Res,2008,6:517-525.
• [27]邓江,黄文良,阮世强.胰岛素样生长因子-1活化组织工程骨修复骨缺损的实验研究[J].第三军医大学学报,2011,2:145-147.
• [28]Barsons P,Butcher A,Hesselden K,et al.Platelet rich concentrate sup-ports human m-esenchymal stem cell proliferation,bone morphogeneticprotein-2m essenger RNA expression,alkaline phosphatase activity,and bone formation in vitro:amode of action to enhance bone repair[J].J Orthop T Raum A,2008,9:595-604.
• [29]刘阳,曹延林,朱立新,等.新型可注射性nHA/CS骨修复材料修复兔股骨髁骨缺损的X线评估[J].中国矫形外科杂志,2011,17:1472-1475.
• [30]王岩松,刘丹平,张元和.纳米羟基磷灰石/聚酰胺66骨填充材料与自体骨修复良性骨肿瘤术后骨缺损的对比研究[J].军医进修学院学报,2011,4:373-374.
• [31]彭超,郭忠鹏,蒋电明,等.聚氨酯/纳米羟基磷灰石+聚酰胺66一体化复合支架材料修复软骨及软骨下骨缺损[J].中国组织工程研究与临床康复,2010,16:2883-2887.
• [32]Lim ST,Berry GP,Brown MB,et al.Preparation and evaluation of the invitro drug release properties and mucoadhesion of novel microspheres of hy-aluronic acid and chitosan[J].J Control Release,2000,1/2:281-292.
• [33]黄金亮,马涛,唐辉.万古霉素阳离子脂质体复合纳米羟基磷灰石/壳聚糖/魔芋葡干聚糖治疗兔慢性感染性骨缺损[J].中华修复与重建外科杂志,2012,2:190-195.
• [34]Ma T,Shang BC,Tang H,et al.Nano-hydroxyapatite/chitosan/konjacglucomannan scaffolds loaded with cationic liposomal vancomycin:prep-aration,in vitro release and activity against staphylococcus aureus bio-films[J].J Bionmater Sci Polym ED,2011,12:1669-1681.
• [35]Zhou G,Li Y,Zhang L,et al.Preparation and characterization of nano-hydroxyapatit/chitosan/konjac glucomannan composite[J].J BiomedMater Res A,2007,4:931-939.